Thomas Templeman
CIK 1654274 · Chief Technology Officer · last filed 2023-04-04
Thomas Templeman is a Chief Technology Officer who has filed 11 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing shows the insider had shares withheld for taxes covering $16.0K of CNTA on Apr 4, 2023. Across all open-market trades the lifetime net is −$12.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$7.62M
3
11
-$12.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CNTA | Chief Technology Officer | 188,244 | $40.50 | $7.62M | -$12.8K | 9 | 2023-04-04 |
| Nuvation Bio Inc. (NUVB.WS) Delisted | SVP, Pharmaceutical Ops | — | $0.01 | — | $0 | 1 | 2021-02-12 |
| MEDIVATION, INC. (MDVN) Delisted | SVP, Pharmaceutical Operations | 22,720 | — | — | $0 | 1 | 2015-10-01 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-04-04 | CNTA | Tax (F) | −4,103 | -$16.0K | EDGAR |
| 2023-02-03 | CNTA | Grant (A) | +60,400 | $0 | EDGAR |
| 2023-01-13 | CNTA | Tax (F) | −5,382 | -$22.9K | EDGAR |
| 2023-01-04 | CNTA | Tax (F) | −2,921 | -$9.1K | EDGAR |
| 2022-11-23 | CNTA | — | — | $0 | EDGAR |
| 2022-10-04 | CNTA | Sell (S) | −4,458 | -$17.8K | EDGAR |
| 2022-07-06 | CNTA | Grant (A) | +140,000 | $0 | EDGAR |
| 2022-02-03 | CNTA | Grant (A) | — | $0 | EDGAR |
| 2021-06-04 | CNTA | Mixed | +250 | $5.0K | EDGAR |
| 2021-02-12 | Nuvation Bio Inc. (NUVB.WS) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.